JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Lifestyle intervention in the management of metabolic syndrome: could we improve adherence issues?

Nutrition 2008 March
Current guidelines for the treatment of the metabolic syndrome (MetSyn) propose lifestyle changes (diet and physical activity) as a first-line intervention. However, few studies have been conducted thus far in this field. Weight loss has been recognized as an important issue in the management of MetSyn, in addition to exercise training. Moreover, improvement in MetSyn parameters was sustained only when changes in lifestyle were maintained, rendering maintenance as an important treatment issue. Multiple follow-up booster sessions proved more effective in maintaining lifestyle changes than one counseling session at the end of follow-up. Several behavioral techniques have also been used to improve patients' adherence. Although most of these were found effective in achieving short-term adherence to the dietary regimen (and exercise treatment), the evidence is limited regarding specific strategies that are most helpful, in the context of a structured, tailored MetSyn intervention, for the long-term maintenance of lifestyle changes.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app